List of SciClone Pharmaceuticals patents

List of SciClone Pharmaceuticals patents

List of Boeing patents

List of NantOmics patents

List of Machine Zone patents

List of companies in Earl Grey Capital's investment portfolio

Psychotherapy venture capital investors

Patents where

Current Assignee

Name

is

‌

SciClone Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8207294 Treatment of	Patent 8207294 was granted and assigned to SciClone Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	8207294	June 26, 2012
	‌ US Patent 8389680 Treatment of	Patent 8389680 was granted and assigned to SciClone Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	8389680	March 5, 2013
	‌ US Patent 8029799 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma	Patent 8029799 was granted and assigned to SciClone Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	8029799	October 4, 2011
	‌ US Patent 8017129 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma	Patent 8017129 was granted and assigned to SciClone Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	8017129	September 13, 2011
	‌ US Patent 9724395 Treatment of cancer with immune stimulators	Patent 9724395 was granted and assigned to SciClone Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	‌ SciClone Pharmaceuticals	‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	9724395	August 8, 2017
	‌ US Patent 7906486 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa	Patent 7906486 was granted and assigned to SciClone Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	7906486	March 15, 2011
	‌ US Patent 7897567 Methods of protecting against radiation damage using alpha thymosin	Patent 7897567 was granted and assigned to SciClone Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	7897567	March 1, 2011
	‌ US Patent 8716012 Alpha thymosin peptides as vaccine enhancers	Patent 8716012 was granted and assigned to SciClone Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	8716012	May 6, 2014
	‌ US Patent 8163702 Treatment of melanoma	Patent 8163702 was granted and assigned to SciClone Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.		‌ SciClone Pharmaceuticals		United States Patent and Trademark Office	8163702	April 24, 2012

9 results

0 selected

9 results

0 selected